カテゴリー： LP Information, 世界, 医療/バイオ

世界の新型コロナウイルス感染症用ヒドロキシクロロキン市場予測 2021年-2026年

【英語タイトル】Global Hydroxychloroquine for COVID-19 Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9641）・商品コード：LPI21MY9641
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：163
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「新型コロナウイルス感染症用ヒドロキシクロロキンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、タブレット、注射など、用途別には、軽度症状患者、重症患者などにセグメント区分してまとめました。新型コロナウイルス感染症用ヒドロキシクロロキンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・新型コロナウイルス感染症用ヒドロキシクロロキンの世界市場概要（サマリー）
・新型コロナウイルス感染症用ヒドロキシクロロキンの企業別販売量・売上
・新型コロナウイルス感染症用ヒドロキシクロロキンの企業別市場シェア
・新型コロナウイルス感染症用ヒドロキシクロロキンの世界市場規模 2016年-2021年：種類別（タブレット、注射）
・新型コロナウイルス感染症用ヒドロキシクロロキンの世界市場規模 2016年-2021年：用途別（軽度症状患者、重症患者）
・新型コロナウイルス感染症用ヒドロキシクロロキンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・新型コロナウイルス感染症用ヒドロキシクロロキンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・新型コロナウイルス感染症用ヒドロキシクロロキンのヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・新型コロナウイルス感染症用ヒドロキシクロロキンの中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・新型コロナウイルス感染症用ヒドロキシクロロキン市場の成長要因・課題・動向
・新型コロナウイルス感染症用ヒドロキシクロロキンの世界市場予測 2021年-2026年
・新型コロナウイルス感染症用ヒドロキシクロロキンの南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・新型コロナウイルス感染症用ヒドロキシクロロキンのアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・新型コロナウイルス感染症用ヒドロキシクロロキンのヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・新型コロナウイルス感染症用ヒドロキシクロロキンの中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・新型コロナウイルス感染症用ヒドロキシクロロキンの世界市場予測：種類別（タブレット、注射）
・新型コロナウイルス感染症用ヒドロキシクロロキンの世界市場予測：用途別（軽度症状患者、重症患者）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Hydroxychloroquine for COVID-19 will have significant change from previous year. By the most conservative estimates of global Hydroxychloroquine for COVID-19 market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Hydroxychloroquine for COVID-19 market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Hydroxychloroquine for COVID-19 market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Tablet
Injection

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Mild Symptom Patient
Critically Ill Patient

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Sanofi
Novartis
Shanghai Zhongxisanwei
Teva
Zydus Cadila
Mylan
Apotex
Advanz Pharma
Sun Pharma
Kyung Poong
Ipca Laboratories
Hanlim Pharmaceutical
Bristol Laboratories

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hydroxychloroquine for COVID-19 Consumption 2016-2026
2.1.2 Hydroxychloroquine for COVID-19 Consumption CAGR by Region
2.2 Hydroxychloroquine for COVID-19 Segment by Type
2.2.1 Tablet
2.2.2 Injection
2.3 Hydroxychloroquine for COVID-19 Sales by Type
2.3.1 Global Hydroxychloroquine for COVID-19 Sales Market Share by Type (2016-2021)
2.3.2 Global Hydroxychloroquine for COVID-19 Revenue and Market Share by Type (2016-2021)
2.3.3 Global Hydroxychloroquine for COVID-19 Sale Price by Type (2016-2021)
2.4 Hydroxychloroquine for COVID-19 Segment by Application
2.4.1 Mild Symptom Patient
2.4.2 Critically Ill Patient
2.5 Hydroxychloroquine for COVID-19 Sales by Application
2.5.1 Global Hydroxychloroquine for COVID-19 Sale Market Share by Application (2016-2021)
2.5.2 Global Hydroxychloroquine for COVID-19 Revenue and Market Share by Application (2016-2021)
2.5.3 Global Hydroxychloroquine for COVID-19 Sale Price by Application (2016-2021)

3 Global Hydroxychloroquine for COVID-19 by Company
3.1 Global Hydroxychloroquine for COVID-19 Sales Market Share by Company
3.1.1 Global Hydroxychloroquine for COVID-19 Sales by Company (2019-2021)
3.1.2 Global Hydroxychloroquine for COVID-19 Sales Market Share by Company (2019-2021)
3.2 Global Hydroxychloroquine for COVID-19 Revenue Market Share by Company
3.2.1 Global Hydroxychloroquine for COVID-19 Revenue by Company (2019-2021)
3.2.2 Global Hydroxychloroquine for COVID-19 Revenue Market Share by Company (2019-2021)
3.3 Global Hydroxychloroquine for COVID-19 Sale Price by Company
3.4 Global Manufacturers Hydroxychloroquine for COVID-19 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hydroxychloroquine for COVID-19 Product Location Distribution
3.4.2 Players Hydroxychloroquine for COVID-19 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Hydroxychloroquine for COVID-19 by Region
4.1 Global Hydroxychloroquine for COVID-19 by Region
4.1.1 Global Hydroxychloroquine for COVID-19 Sales by Region
4.1.2 Global Hydroxychloroquine for COVID-19 Revenue by Region
4.2 Americas Hydroxychloroquine for COVID-19 Sales Growth
4.3 APAC Hydroxychloroquine for COVID-19 Sales Growth
4.4 Europe Hydroxychloroquine for COVID-19 Sales Growth
4.5 Middle East & Africa Hydroxychloroquine for COVID-19 Sales Growth

5 Americas
5.1 Americas Hydroxychloroquine for COVID-19 Sales by Country
5.1.1 Americas Hydroxychloroquine for COVID-19 Sales by Country (2016-2021)
5.1.2 Americas Hydroxychloroquine for COVID-19 Revenue by Country (2016-2021)
5.2 Americas Hydroxychloroquine for COVID-19 Sales by Type
5.3 Americas Hydroxychloroquine for COVID-19 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Hydroxychloroquine for COVID-19 Sales by Region
6.1.1 APAC Hydroxychloroquine for COVID-19 Sales by Region (2016-2021)
6.1.2 APAC Hydroxychloroquine for COVID-19 Revenue by Region (2016-2021)
6.2 APAC Hydroxychloroquine for COVID-19 Sales by Type
6.3 APAC Hydroxychloroquine for COVID-19 Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Hydroxychloroquine for COVID-19 by Country
7.1.1 Europe Hydroxychloroquine for COVID-19 Sales by Country (2016-2021)
7.1.2 Europe Hydroxychloroquine for COVID-19 Revenue by Country (2016-2021)
7.2 Europe Hydroxychloroquine for COVID-19 Sales by Type
7.3 Europe Hydroxychloroquine for COVID-19 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Hydroxychloroquine for COVID-19 by Country
8.1.1 Middle East & Africa Hydroxychloroquine for COVID-19 Sales by Country (2016-2021)
8.1.2 Middle East & Africa Hydroxychloroquine for COVID-19 Revenue by Country (2016-2021)
8.2 Middle East & Africa Hydroxychloroquine for COVID-19 Sales by Type
8.3 Middle East & Africa Hydroxychloroquine for COVID-19 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Hydroxychloroquine for COVID-19 Distributors
10.3 Hydroxychloroquine for COVID-19 Customer

11 Global Hydroxychloroquine for COVID-19 Market Forecast
11.1 Global Hydroxychloroquine for COVID-19 Forecast by Region
11.1.1 Global Hydroxychloroquine for COVID-19 Forecast by Regions (2021-2026)
11.2.2 Global Hydroxychloroquine for COVID-19 Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Hydroxychloroquine for COVID-19 Forecast by Type
11.7 Global Hydroxychloroquine for COVID-19 Forecast by Application

12 Key Players Analysis
12.1 Sanofi
12.1.1 Sanofi Sanofi Company Information
12.1.2 Sanofi Hydroxychloroquine for COVID-19 Product Offered
12.1.3 Sanofi Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Sanofi Main Business Overview
12.1.5 Sanofi Latest Developments
12.2 Novartis
12.2.1 Novartis Company Information
12.2.2 Novartis Hydroxychloroquine for COVID-19 Product Offered
12.2.3 Novartis Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novartis Main Business Overview
12.2.5 Novartis Latest Developments
12.3 Shanghai Zhongxisanwei
12.3.1 Shanghai Zhongxisanwei Company Information
12.3.2 Shanghai Zhongxisanwei Hydroxychloroquine for COVID-19 Product Offered
12.3.3 Shanghai Zhongxisanwei Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Shanghai Zhongxisanwei Main Business Overview
12.3.5 Shanghai Zhongxisanwei Latest Developments
12.4 Teva
12.4.1 Teva Company Information
12.4.2 Teva Hydroxychloroquine for COVID-19 Product Offered
12.4.3 Teva Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Teva Main Business Overview
12.4.5 Teva Latest Developments
12.5 Zydus Cadila
12.5.1 Zydus Cadila Company Information
12.5.2 Zydus Cadila Hydroxychloroquine for COVID-19 Product Offered
12.5.3 Zydus Cadila Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Zydus Cadila Main Business Overview
12.5.5 Zydus Cadila Latest Developments
12.6 Mylan
12.6.1 Mylan Company Information
12.6.2 Mylan Hydroxychloroquine for COVID-19 Product Offered
12.6.3 Mylan Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Mylan Main Business Overview
12.6.5 Mylan Latest Developments
12.7 Apotex
12.7.1 Apotex Company Information
12.7.2 Apotex Hydroxychloroquine for COVID-19 Product Offered
12.7.3 Apotex Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Apotex Main Business Overview
12.7.5 Apotex Latest Developments
12.8 Advanz Pharma
12.8.1 Advanz Pharma Company Information
12.8.2 Advanz Pharma Hydroxychloroquine for COVID-19 Product Offered
12.8.3 Advanz Pharma Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Advanz Pharma Main Business Overview
12.8.5 Advanz Pharma Latest Developments
12.9 Sun Pharma
12.9.1 Sun Pharma Company Information
12.9.2 Sun Pharma Hydroxychloroquine for COVID-19 Product Offered
12.9.3 Sun Pharma Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Sun Pharma Main Business Overview
12.9.5 Sun Pharma Latest Developments
12.10 Kyung Poong
12.10.1 Kyung Poong Company Information
12.10.2 Kyung Poong Hydroxychloroquine for COVID-19 Product Offered
12.10.3 Kyung Poong Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Kyung Poong Main Business Overview
12.10.5 Kyung Poong Latest Developments
12.11 Ipca Laboratories
12.11.1 Ipca Laboratories Company Information
12.11.2 Ipca Laboratories Hydroxychloroquine for COVID-19 Product Offered
12.11.3 Ipca Laboratories Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Ipca Laboratories Main Business Overview
12.11.5 Ipca Laboratories Latest Developments
12.12 Hanlim Pharmaceutical
12.12.1 Hanlim Pharmaceutical Company Information
12.12.2 Hanlim Pharmaceutical Hydroxychloroquine for COVID-19 Product Offered
12.12.3 Hanlim Pharmaceutical Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Hanlim Pharmaceutical Main Business Overview
12.12.5 Hanlim Pharmaceutical Latest Developments
12.13 Bristol Laboratories
12.13.1 Bristol Laboratories Company Information
12.13.2 Bristol Laboratories Hydroxychloroquine for COVID-19 Product Offered
12.13.3 Bristol Laboratories Hydroxychloroquine for COVID-19 Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Bristol Laboratories Main Business Overview
12.13.5 Bristol Laboratories Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Hydroxychloroquine for COVID-19 Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Tablet
Table 3. Major Players of Injection
Table 4. Global Hydroxychloroquine for COVID-19 Sales by Type (2016-2021) & (Tons)
Table 5. Global Hydroxychloroquine for COVID-19 Sales Market Share by Type (2016-2021)
Table 6. Global Hydroxychloroquine for COVID-19 Revenue by Type (2016-2021) & ($ million)
Table 7. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Type (2016-2021)
Table 8. Global Hydroxychloroquine for COVID-19 Sale Price by Type (2016-2021)
Table 9. Global Hydroxychloroquine for COVID-19 Sales by Application (2016-2021) & (Tons)
Table 10. Global Hydroxychloroquine for COVID-19 Sales Market Share by Application (2016-2021)
Table 11. Global Hydroxychloroquine for COVID-19 Value by Application (2016-2021)
Table 12. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Application (2016-2021)
Table 13. Global Hydroxychloroquine for COVID-19 Sale Price by Application (2016-2021)
Table 14. Global Hydroxychloroquine for COVID-19 Sales by Company (2019-2021) & (Tons)
Table 15. Global Hydroxychloroquine for COVID-19 Sales Market Share by Company (2019-2021)
Table 16. Global Hydroxychloroquine for COVID-19 Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Company (2019-2021)
Table 18. Global Hydroxychloroquine for COVID-19 Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Hydroxychloroquine for COVID-19 Producing Area Distribution and Sales Area
Table 20. Players Hydroxychloroquine for COVID-19 Products Offered
Table 21. Hydroxychloroquine for COVID-19 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Hydroxychloroquine for COVID-19 Sales by Region (2016-2021) (Tons)
Table 25. Global Hydroxychloroquine for COVID-19 Sales Market Share by Region (2016-2021)
Table 26. Global Hydroxychloroquine for COVID-19 Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Region (2016-2021)
Table 28. Americas Hydroxychloroquine for COVID-19 Sales by Country (2016-2021) & (Tons)
Table 29. Americas Hydroxychloroquine for COVID-19 Sales Market Share by Country (2016-2021)
Table 30. Americas Hydroxychloroquine for COVID-19 Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Hydroxychloroquine for COVID-19 Revenue Market Share by Country (2016-2021)
Table 32. Americas Hydroxychloroquine for COVID-19 Sales by Type (2016-2021) & (Tons)
Table 33. Americas Hydroxychloroquine for COVID-19 Sales Market Share by Type (2016-2021)
Table 34. Americas Hydroxychloroquine for COVID-19 Sales by Application (2016-2021) & (Tons)
Table 35. Americas Hydroxychloroquine for COVID-19 Sales Market Share by Application (2016-2021)
Table 36. APAC Hydroxychloroquine for COVID-19 Sales by Region (2016-2021) & (Tons)
Table 37. APAC Hydroxychloroquine for COVID-19 Sales Market Share by Region (2016-2021)
Table 38. APAC Hydroxychloroquine for COVID-19 Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Hydroxychloroquine for COVID-19 Revenue Market Share by Region (2016-2021)
Table 40. APAC Hydroxychloroquine for COVID-19 Sales by Type (2016-2021) & (Tons)
Table 41. APAC Hydroxychloroquine for COVID-19 Sales Market Share by Type (2016-2021)
Table 42. APAC Hydroxychloroquine for COVID-19 Sales by Application (2016-2021) & (Tons)
Table 43. APAC Hydroxychloroquine for COVID-19 Sales Market Share by Application (2016-2021)
Table 44. Europe Hydroxychloroquine for COVID-19 Sales by Country (2016-2021) & (Tons)
Table 45. Europe Hydroxychloroquine for COVID-19 Sales Market Share by Country (2016-2021)
Table 46. Europe Hydroxychloroquine for COVID-19 Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Hydroxychloroquine for COVID-19 Revenue Market Share by Country (2016-2021)
Table 48. Europe Hydroxychloroquine for COVID-19 Sales by Type (2016-2021) & (Tons)
Table 49. Europe Hydroxychloroquine for COVID-19 Sales Market Share by Type (2016-2021)
Table 50. Europe Hydroxychloroquine for COVID-19 Sales by Application (2016-2021) & (Tons)
Table 51. Europe Hydroxychloroquine for COVID-19 Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Hydroxychloroquine for COVID-19 Sales by Country (2016-2021) & (Tons)
Table 53. Middle East & Africa Hydroxychloroquine for COVID-19 Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Hydroxychloroquine for COVID-19 Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Hydroxychloroquine for COVID-19 Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Hydroxychloroquine for COVID-19 Sales by Type (2016-2021) & (Tons)
Table 57. Middle East & Africa Hydroxychloroquine for COVID-19 Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Hydroxychloroquine for COVID-19 Sales by Application (2016-2021) & (Tons)
Table 59. Middle East & Africa Hydroxychloroquine for COVID-19 Sales Market Share by Application (2016-2021)
Table 60. Global Hydroxychloroquine for COVID-19 Sales Forecast by Type (2021-2026) & (Tons)
Table 61. Global Hydroxychloroquine for COVID-19 Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Hydroxychloroquine for COVID-19 Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Hydroxychloroquine for COVID-19 Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Hydroxychloroquine for COVID-19 Sales Forecast by Application (2021-2026) & (Tons)
Table 65. Global Hydroxychloroquine for COVID-19 Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Hydroxychloroquine for COVID-19 Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Hydroxychloroquine for COVID-19 Revenue Market Share Forecast by Application (2021-2026)
Table 68. Sanofi Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 69. Sanofi Hydroxychloroquine for COVID-19 Product Offered
Table 70. Sanofi Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 71. Sanofi Main Business
Table 72. Sanofi Latest Developments
Table 73. Novartis Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis Hydroxychloroquine for COVID-19 Product Offered
Table 75. Novartis Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Shanghai Zhongxisanwei Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 79. Shanghai Zhongxisanwei Hydroxychloroquine for COVID-19 Product Offered
Table 80. Shanghai Zhongxisanwei Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 81. Shanghai Zhongxisanwei Main Business
Table 82. Shanghai Zhongxisanwei Latest Developments
Table 83. Teva Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Hydroxychloroquine for COVID-19 Product Offered
Table 85. Teva Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 86. Teva Main Business
Table 87. Teva Latest Developments
Table 88. Zydus Cadila Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 89. Zydus Cadila Hydroxychloroquine for COVID-19 Product Offered
Table 90. Zydus Cadila Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 91. Zydus Cadila Main Business
Table 92. Zydus Cadila Latest Developments
Table 93. Mylan Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 94. Mylan Hydroxychloroquine for COVID-19 Product Offered
Table 95. Mylan Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 96. Mylan Main Business
Table 97. Mylan Latest Developments
Table 98. Apotex Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 99. Apotex Hydroxychloroquine for COVID-19 Product Offered
Table 100. Apotex Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 101. Apotex Main Business
Table 102. Apotex Latest Developments
Table 103. Advanz Pharma Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 104. Advanz Pharma Hydroxychloroquine for COVID-19 Product Offered
Table 105. Advanz Pharma Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 106. Advanz Pharma Main Business
Table 107. Advanz Pharma Latest Developments
Table 108. Sun Pharma Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 109. Sun Pharma Hydroxychloroquine for COVID-19 Product Offered
Table 110. Sun Pharma Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 111. Sun Pharma Main Business
Table 112. Sun Pharma Latest Developments
Table 113. Kyung Poong Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 114. Kyung Poong Hydroxychloroquine for COVID-19 Product Offered
Table 115. Kyung Poong Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 116. Kyung Poong Main Business
Table 117. Kyung Poong Latest Developments
Table 118. Ipca Laboratories Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 119. Ipca Laboratories Hydroxychloroquine for COVID-19 Product Offered
Table 120. Ipca Laboratories Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 121. Ipca Laboratories Main Business
Table 122. Ipca Laboratories Latest Developments
Table 123. Hanlim Pharmaceutical Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 124. Hanlim Pharmaceutical Hydroxychloroquine for COVID-19 Product Offered
Table 125. Hanlim Pharmaceutical Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 126. Hanlim Pharmaceutical Main Business
Table 127. Hanlim Pharmaceutical Latest Developments
Table 128. Bristol Laboratories Basic Information, Hydroxychloroquine for COVID-19 Manufacturing Base, Sales Area and Its Competitors
Table 129. Bristol Laboratories Hydroxychloroquine for COVID-19 Product Offered
Table 130. Bristol Laboratories Hydroxychloroquine for COVID-19 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 131. Bristol Laboratories Main Business
Table 132. Bristol Laboratories Latest Developments
List of Figures
Figure 1. Picture of Hydroxychloroquine for COVID-19
Figure 2. Hydroxychloroquine for COVID-19 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hydroxychloroquine for COVID-19 Sales Growth Rate 2016-2026 (Tons)
Figure 7. Global Hydroxychloroquine for COVID-19 Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Hydroxychloroquine for COVID-19 Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Injection
Figure 11. Global Hydroxychloroquine for COVID-19 Sales Market Share by Type in 2020
Figure 12. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Type (2016-2021)
Figure 13. Hydroxychloroquine for COVID-19 Consumed in Mild Symptom Patient
Figure 14. Global Hydroxychloroquine for COVID-19 Market: Mild Symptom Patient (2016-2021) & (Tons)
Figure 15. Hydroxychloroquine for COVID-19 Consumed in Critically Ill Patient
Figure 16. Global Hydroxychloroquine for COVID-19 Market: Critically Ill Patient (2016-2021) & (Tons)
Figure 17. Global Hydroxychloroquine for COVID-19 Sales Market Share by Application (2016-2021)
Figure 18. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Application in 2020
Figure 19. Global Hydroxychloroquine for COVID-19 Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Company in 2020
Figure 21. Global Hydroxychloroquine for COVID-19 Sales Market Share by Regions (2016-2021)
Figure 22. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Region in 2020
Figure 23. Americas Hydroxychloroquine for COVID-19 Sales 2016-2021 (Tons)
Figure 24. Americas Hydroxychloroquine for COVID-19 Revenue 2016-2021 ($ Millions)
Figure 25. APAC Hydroxychloroquine for COVID-19 Sales 2016-2021 (Tons)
Figure 26. APAC Hydroxychloroquine for COVID-19 Revenue 2016-2021 ($ Millions)
Figure 27. Europe Hydroxychloroquine for COVID-19 Sales 2016-2021 (Tons)
Figure 28. Europe Hydroxychloroquine for COVID-19 Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Hydroxychloroquine for COVID-19 Sales 2016-2021 (Tons)
Figure 30. Middle East & Africa Hydroxychloroquine for COVID-19 Revenue 2016-2021 ($ Millions)
Figure 31. Americas Hydroxychloroquine for COVID-19 Sales Market Share by Country in 2020
Figure 32. Americas Hydroxychloroquine for COVID-19 Revenue Market Share by Country in 2020
Figure 33. Americas Hydroxychloroquine for COVID-19 Sales Market Share by Type in 2020
Figure 34. Americas Hydroxychloroquine for COVID-19 Sales Market Share by Application in 2020
Figure 35. United States Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Hydroxychloroquine for COVID-19 Sales Market Share by Region in 2020
Figure 40. APAC Hydroxychloroquine for COVID-19 Revenue Market Share by Regions in 2020
Figure 41. APAC Hydroxychloroquine for COVID-19 Sales Market Share by Type in 2020
Figure 42. APAC Hydroxychloroquine for COVID-19 Sales Market Share by Application in 2020
Figure 43. China Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Hydroxychloroquine for COVID-19 Sales Market Share by Country in 2020
Figure 50. Europe Hydroxychloroquine for COVID-19 Revenue Market Share by Country in 2020
Figure 51. Europe Hydroxychloroquine for COVID-19 Sales Market Share by Type in 2020
Figure 52. Europe Hydroxychloroquine for COVID-19 Sales Market Share by Application in 2020
Figure 53. Germany Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Hydroxychloroquine for COVID-19 Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Hydroxychloroquine for COVID-19 Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Hydroxychloroquine for COVID-19 Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Hydroxychloroquine for COVID-19 Sales Market Share by Application in 2020
Figure 62. Egypt Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Hydroxychloroquine for COVID-19 Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles


★調査レポート[世界の新型コロナウイルス感染症用ヒドロキシクロロキン市場予測 2021年-2026年] (コード：LPI21MY9641)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の新型コロナウイルス感染症用ヒドロキシクロロキン市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の迅速型新型コロナウイルス感染症検査機市場予測 2021年-2026年
    LPI21MY9018 / LP Information / 2021年5月 / LPインフォメーション社の「迅速型新型コロナウイルス感染症検査機の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、鼻腔スワブ、喉スワブ、鼻咽頭スワブなど、用途別には、病院、診療所、住宅用、その他などにセグメント区分してまとめました。迅速型新型コロナウイルス感染症検査機のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・迅速型新型コロナウイルス感染症検査機の世界市場概要（サマリー） ・迅速型新型コロナウイルス感染症検査機の企業別販売量・売上 ・迅速型新型コロナウイルス感染症検査機の企業別市場シェア ・迅速型新型コロナウイルス感染症検査機の世界市場規模 2016年-2021年：種類別（鼻腔スワブ、喉スワブ、鼻咽頭スワブ） ・迅速型新型コロナウイルス感染症検査機の世界市場規模 2016年-2021年：用途別（病院、診療所、住宅用、その他） ・迅速型新型コロナウイルス感染症検査機の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・迅速型新型コロナウイルス感染症検査機のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Rapid Covid Test Machine will have significant change from previous year. By the most conservative estimates of global Rapid Covid Test Machine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Rapid Covid Test Machine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Covid Test Machine...
  • 世界の迅速型新型コロナウイルス感染症検査装置市場予測 2021年-2026年
    LPI21MY9356 / LP Information / 2021年5月 / LPインフォメーション社の「迅速型新型コロナウイルス感染症検査装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、使い捨て、再利用可能など、用途別には、病院、診療所、住宅用、その他などにセグメント区分してまとめました。迅速型新型コロナウイルス感染症検査装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・迅速型新型コロナウイルス感染症検査装置の世界市場概要（サマリー） ・迅速型新型コロナウイルス感染症検査装置の企業別販売量・売上 ・迅速型新型コロナウイルス感染症検査装置の企業別市場シェア ・迅速型新型コロナウイルス感染症検査装置の世界市場規模 2016年-2021年：種類別（使い捨て、再利用可能） ・迅速型新型コロナウイルス感染症検査装置の世界市場規模 2016年-2021年：用途別（病院、診療所、住宅用、その他） ・迅速型新型コロナウイルス感染症検査装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・迅速型新型コロナウイルス感染症検査装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Rapid COVID-19 Testing Devices will have significant change from previous year. By the most conservative estimates of global Rapid COVID-19 Testing Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Rapid COVID-19 Testing Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Rapid COVID-19 Testing Devices...
  • 世界の新型コロナウイルス感染症用クロロキン薬剤市場予測 2021年-2026年
    LPI21MY9481 / LP Information / 2021年5月 / LPインフォメーション社の「新型コロナウイルス感染症用クロロキン薬剤の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、錠剤、注射など、用途別には、軽症患者、重症患者などにセグメント区分してまとめました。新型コロナウイルス感染症用クロロキン薬剤のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・新型コロナウイルス感染症用クロロキン薬剤の世界市場概要（サマリー） ・新型コロナウイルス感染症用クロロキン薬剤の企業別販売量・売上 ・新型コロナウイルス感染症用クロロキン薬剤の企業別市場シェア ・新型コロナウイルス感染症用クロロキン薬剤の世界市場規模 2016年-2021年：種類別（錠剤、注射） ・新型コロナウイルス感染症用クロロキン薬剤の世界市場規模 2016年-2021年：用途別（軽症患者、重症患者） ・新型コロナウイルス感染症用クロロキン薬剤の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・新型コロナウイルス感染症用クロロキン薬剤のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Chloroquine Drug for COVID-19 will have significant change from previous year. By the most conservative estimates of global Chloroquine Drug for COVID-19 market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Chloroquine Drug for COVID-19 market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Chloroquine Drug for COVID-19...
  • 世界のヒドロキシクロロキン硫酸塩市場予測 2021年-2026年
    LPI21MY2538 / LP Information / 2021年5月 / LPインフォメーション社の「ヒドロキシクロロキン硫酸塩の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、USP規格、EP規格、医薬品規格、その他など、用途別には、関節リウマチ、青年期慢性関節、円板状エリテマトーデス＆全身性エリテマトーデス、皮膚病変などにセグメント区分してまとめました。ヒドロキシクロロキン硫酸塩のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ヒドロキシクロロキン硫酸塩の世界市場概要（サマリー） ・ヒドロキシクロロキン硫酸塩の企業別販売量・売上 ・ヒドロキシクロロキン硫酸塩の企業別市場シェア ・ヒドロキシクロロキン硫酸塩の世界市場規模 2016年-2021年：種類別（USP規格、EP規格、医薬品規格、その他） ・ヒドロキシクロロキン硫酸塩の世界市場規模 2016年-2021年：用途別（関節リウマチ、青年期慢性関節、円板状エリテマトーデス＆全身性エリテマトーデス、皮膚病変） ・ヒドロキシクロロキン硫酸塩の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ヒドロキシクロロキン硫酸塩のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Hydroxychloroquine Sulfate will have significant change from previous year. By the most conservative estimates of global Hydroxychloroquine Sulfate market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Hydroxychloroquine Sulfate market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Hydroxychloroquine Sulfate market by product type, application, key manufacturers and...
  • 世界の新型コロナウイルスワクチン用ガラス瓶市場予測 2021年-2026年
    LPI21MY9389 / LP Information / 2021年5月 / LPインフォメーション社の「新型コロナウイルスワクチン用ガラス瓶の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、中ホウ酸塩ホウケイ酸ガラス、低ホウ酸塩ホウケイ酸ガラスなど、用途別には、ワクチン製造、ワクチン研究などにセグメント区分してまとめました。新型コロナウイルスワクチン用ガラス瓶のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・新型コロナウイルスワクチン用ガラス瓶の世界市場概要（サマリー） ・新型コロナウイルスワクチン用ガラス瓶の企業別販売量・売上 ・新型コロナウイルスワクチン用ガラス瓶の企業別市場シェア ・新型コロナウイルスワクチン用ガラス瓶の世界市場規模 2016年-2021年：種類別（中ホウ酸塩ホウケイ酸ガラス、低ホウ酸塩ホウケイ酸ガラス） ・新型コロナウイルスワクチン用ガラス瓶の世界市場規模 2016年-2021年：用途別（ワクチン製造、ワクチン研究） ・新型コロナウイルスワクチン用ガラス瓶の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・新型コロナウイルスワクチン用ガラス瓶のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Vials for COVID-19 Vaccine will have significant change from previous year. By the most conservative estimates of global Vials for COVID-19 Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Vials for COVID-19 Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Vials for COVID-19 Vaccine...
  • 世界のクロロキン薬剤市場予測 2021年-2026年
    LPI21MY9480 / LP Information / 2021年5月 / LPインフォメーション社の「クロロキン薬剤の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、錠剤、注射など、用途別には、関節炎、マラリア、新型コロナウイルス感染症、その他などにセグメント区分してまとめました。クロロキン薬剤のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・クロロキン薬剤の世界市場概要（サマリー） ・クロロキン薬剤の企業別販売量・売上 ・クロロキン薬剤の企業別市場シェア ・クロロキン薬剤の世界市場規模 2016年-2021年：種類別（錠剤、注射） ・クロロキン薬剤の世界市場規模 2016年-2021年：用途別（関節炎、マラリア、新型コロナウイルス感染症、その他） ・クロロキン薬剤の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・クロロキン薬剤のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Chloroquine Drug will have significant change from previous year. By the most conservative estimates of global Chloroquine Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Chloroquine Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Chloroquine Drug market by product type, application, key manufacturers and...
  • 世界のヒドロキシクロロキン硫酸市場 2019年
    DATA909X09494 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヒドロキシクロロキン硫酸の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、100mgヒドロキシクロロキン硫酸塩、200mgヒドロキシクロロキン硫酸塩に、用途別には、円板状エリテマトーデス、全身性エリテマトーデス、その他にセグメント区分し、ヒドロキシクロロキン硫酸の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヒドロキシクロロキン硫酸の世界市場概要 ・ヒドロキシクロロキン硫酸の製造コスト構成分析 ・ヒドロキシクロロキン硫酸の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヒドロキシクロロキン硫酸の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヒドロキシクロロキン硫酸のセグメント分析（種類別） （100mgヒドロキシクロロキン硫酸塩、200mgヒドロキシクロロキン硫酸塩）...The global Hydroxychloroquine Sulphate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hydroxychloroquine Sulphate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hydroxychloroquine Sulphate market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hydroxychloroquine Sulphate in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hydroxychloroquine Sulphate manufacturing...
  • 世界のエリキュース市場予測 2021年-2026年
    LPI21MY9515 / LP Information / 2021年5月 / LPインフォメーション社の「エリキュースの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、2.5mg、5mgなど、用途別には、深部静脈血栓症（DVT）、肺塞栓症（PE）などにセグメント区分してまとめました。エリキュースのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・エリキュースの世界市場概要（サマリー） ・エリキュースの企業別販売量・売上 ・エリキュースの企業別市場シェア ・エリキュースの世界市場規模 2016年-2021年：種類別（2.5mg、5mg） ・エリキュースの世界市場規模 2016年-2021年：用途別（深部静脈血栓症（DVT）、肺塞栓症（PE）） ・エリキュースの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・エリキュースのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Eliquis will have significant change from previous year. By the most conservative estimates of global Eliquis market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Eliquis market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Eliquis market by product type, application, key manufacturers and key regions and countries....
  • 世界の注射用オマリズマブ市場予測 2021年-2026年
    LPI21MY9606 / LP Information / 2021年5月 / LPインフォメーション社の「注射用オマリズマブの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、注射用皮下粉末、皮下液（150mg / mL）、皮下液（75mg / 0.5mL）など、用途別には、病院、診療所などにセグメント区分してまとめました。注射用オマリズマブのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・注射用オマリズマブの世界市場概要（サマリー） ・注射用オマリズマブの企業別販売量・売上 ・注射用オマリズマブの企業別市場シェア ・注射用オマリズマブの世界市場規模 2016年-2021年：種類別（注射用皮下粉末、皮下液（150mg...According to this latest study, the 2020 growth of Omalizumab for Injection will have significant change from previous year. By the most conservative estimates of global Omalizumab for Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Omalizumab for Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Omalizumab for Injection market by product type,...
  • 世界のゴセレリン薬市場予測 2021年-2026年
    LPI21MY9545 / LP Information / 2021年5月 / LPインフォメーション社の「ゴセレリン薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、3.6mg、10.8mgなど、用途別には、前立腺がん、乳がん、子宮内膜症、その他などにセグメント区分してまとめました。ゴセレリン薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ゴセレリン薬の世界市場概要（サマリー） ・ゴセレリン薬の企業別販売量・売上 ・ゴセレリン薬の企業別市場シェア ・ゴセレリン薬の世界市場規模 2016年-2021年：種類別（3.6mg、10.8mg） ・ゴセレリン薬の世界市場規模 2016年-2021年：用途別（前立腺がん、乳がん、子宮内膜症、その他） ・ゴセレリン薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ゴセレリン薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Goserelin Drug will have significant change from previous year. By the most conservative estimates of global Goserelin Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Goserelin Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Goserelin Drug market by product type, application, key manufacturers and...

    • ◆H&Iグローバルリサーチのお客様（例）◆